Search results
Results from the WOW.Com Content Network
The Securities and Exchange Commission sued Stifel Nicolaus on August 10, 2011, claiming the firm duped five Wisconsin school districts into buying $200 million in "unsuitable" securities tied to collateralized debt obligations. The investments, which the school districts had purchased in 2006 with $163 million in borrowed funds and $37 million ...
James L. Johnson - Senior Vice President, Stifel Nicolaus & Co. James P. Kavanaugh - CEO, World Wide Technology, Inc. Jerald L. Kent - Chairman and CEO, TierPoint, LLC & CEO, Cequel III. Donn S. Lux - Chairman of the Board & CEO, Luxco. W. Stephen Maritz - Chairman of the Board, Maritz Inc. Scott B. McCuaig - Former President, Stifel Nicolaus & Co.
Keefe, Bruyette & Woods, Inc., a Stifel Company, is an investment banking firm headquartered in New York City, specializing exclusively in the financial services sector.. KBW's primary business lines include research, corporate finance, equity sales and trading, equity capital markets, debt capital markets, and asset managem
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of KBW Inc. in Connection with the Sale of the Company to Stifel Financial ...
BioLineRx Enters into "At-The-Market" Offering Agreement with Stifel, Nicolaus & Company JERUSALEM--(BUSINESS WIRE)-- BioLineRx Ltd. (NAS: BLRX) (TASE: BLRX), a biopharmaceutical development ...
For premium support please call: 800-290-4726 more ways to reach us
Ronald James Kruszewski is an American business executive. Kruszewski is the chairman, chief executive officer, and former president of Stifel. [1] [2] Earlier in his career, he was a Certified Public Accountant and audit supervisor for KPMG, and later a chief financial officer for Robert W. Baird & Co. Kruszewski was appointed to serve on the Federal Advisory Council by the board of the ...
Idera to Present at the Stifel Nicolaus 2013 Healthcare Conference CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Idera Pharmaceuticals, Inc. (NAS: IDRA) today announced that the Company will be presenting ...